某三级中心一年内综合主动脉服务项目的成本效果与临床结局分析
该单中心回顾性研究纳入109例初次或既往腹主动脉修复相关手术患者并随访1年,比较开窗EVAR(FEVAR)、标准EVAR与开放修复(OSR)的成本与结局,发现FEVAR、EVAR与OSR均具成本效果且结局相似,开放修复住院时间和呼吸系统并发症增加。
要点
- FEVAR、标准EVAR与OSR每患者平均成本分别为£16,041.53、£13,893.51与£15,357.22,组间比较均无显著差异。
- 开放修复较血管内修复住院时间延长且呼吸系统并发症增加,30天和1年死亡率组间无显著差异。
- 作者认为在专科中心开展时,FEVAR或可作为开放修复的可行替代选择,尤其适用于较高危人群。
核心结论
- FEVAR、EVAR与OSR均为具成本效果的主修复选项且结局相似;作者认为在专科中心实施时,FEVAR或可成为开放修复的可行替代选择,尤其适用于较高危人群。
研究设计与样本
- 单中心回顾性研究,纳入109例接受与本次或既往腹主动脉修复相关手术的患者,随访1年。
- 数据来自国家血管登记处与医院病历。
主要发现
- 每患者平均成本:FEVAR £16,041.53(±8,857.54),标准EVAR £13,893.51(±£21,425.25),OSR £15,357.22(±£15,904.49);FEVAR vs EVAR P=0.55,FEVAR vs OSR P=0.83,OSR vs EVAR P=0.76。
- 开放修复患者较血管内修复患者住院时间延长且呼吸系统并发症增加。
- 30天死亡率与1年死亡率组间均无显著差异。
关键数值与推荐
- 主要结局为每质量调整生命年成本。
- 次要结局包括择期初次手术的30天死亡率与并发症、再干预率、住院时间、动脉瘤死亡率及1年全因死亡率。
临床怎么用
- 作者认为,在专科中心开展时,FEVAR或可成为开放修复的可行替代选择,尤其适用于较高危人群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular aortic repair (EVAR) is an established and attractive alternative to open surgical repair (OSR) of abdominal aortic aneurysms (AAA) due to its superior short-term safety profile. However, opinions are divided regarding its long-term cost-effectiveness. We compared the total yearly cost of running endovascular and OSR services in a single tertiary center to determine whether fenestrated EVAR (FEVAR) represents a clinically efficacious, affordable treatment option. METHODS: A single-center retrospective review was performed on 109 patients undergoing a procedure related to index or previous abdominal aortic repair, with 1 year follow-up. Data was collected from the National Vascular Registry and hospital records. The primary outcome was cost per quality-adjusted life year. Secondary outcomes included 30-day mortality and morbidity, reintervention rates, length of hospital stay, aneurysm, and all-cause mortality at 1 year for elective index procedures. RESULTS: The average cost per patient of all FEVAR was £16,041.53 (±8,857.54), £13,893.51 (±£21,425.25) for standard EVAR, and £15,357.22 (±£15,904.49) for OSR (FEVAR versus EVAR P = 0.55, FEVAR versus OSR P = 0.83, OSR versus EVAR P = 0.76). Of the secondary outcomes, significant findings included increased length of stay and respiratory morbidity for patients undergoing open versus endovascular repair. There was no significant difference in 30-day or 1-year mortality between groups. CONCLUSIONS: FEVAR, EVAR, and OSR all represent cost-effective options for aortic repair with similar outcomes. Our data highlights the potential for FEVAR to present a viable alternative to open repair, particularly in higher-risk groups, when performed in specialist centers.
引用
- Songra LAK, Baker DM, Agu O, et al. An Analysis of Cost-Effectiveness and Clinical Outcomes of a Comprehensive Aortic Service in a Tertiary Center over One Year. Ann Vasc Surg. 2023. PMID: 37926139. doi:10.1016/j.avsg.2023.09.084
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。